Cargando…
Industrialization’s eye view on theranostic nanomedicine
The emergence of nanomedicines (NMs) in the healthcare industry will bring about groundbreaking improvements to the current therapeutic and diagnostic scenario. However, only a few NMs have been developed into clinical applications due to a lack of regulatory experience with them. In this article, w...
Autores principales: | Sivasubramanian, Maharajan, Lin, Li-Jie, Wang, Yu-Chao, Yang, Chung-Shi, Lo, Leu-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437266/ https://www.ncbi.nlm.nih.gov/pubmed/36059870 http://dx.doi.org/10.3389/fchem.2022.918715 |
Ejemplares similares
-
Advanced Peptide Nanomedicines for Bladder Cancer Theranostics
por: Zeng, Sheng, et al.
Publicado: (2022) -
Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics
por: Mao, Yuqiang, et al.
Publicado: (2020) -
Assessment of Nanoparticle-Mediated Tumor Oxygen Modulation by Photoacoustic Imaging
por: Sivasubramanian, Maharajan, et al.
Publicado: (2022) -
Microbial transglutaminase nanoflowers as an alternative nanomedicine for breast cancer theranostics
por: Fatima, Syeda Warisul, et al.
Publicado: (2021) -
Nanoparticle-facilitated functional and molecular imaging for the early detection of cancer
por: Sivasubramanian, Maharajan, et al.
Publicado: (2014)